These findings suggest that G-17 and the CCK2 receptor may play important roles in the development of gastrointestinal cancer by activating downstream signaling pathways, such as the JAK2/STAT3, PI3K2, and PI3K2/AKT pathways, among others, which in turn promote tumor cell proliferation, migration, and invasion. Here, JAK2 is linked to neoplasm.